Andrea C. LeBlanc Caspase-6 as a novel early target in the treatment of Alzheimer's disease European Journal of Neuroscience 37
Caspase-6 activity is intimately associated with Alzheimer Disease pathological hallmarks and cognitive impairment. The action of Caspase-6 results in the proteolysis of several neuronal proteins that could affect in parallel many cellular functions. This paper summarizes the evidence for Caspase-6 in Alzheimer Disease and examines the possibility that inhibiting Caspase-6 may provide an efficient treatment against early cognitive impairment and progression to dementia in Alzheimer Disease.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf